Raid AlJumaily

University of Oklahoma, OK

Hematology/Oncology, joined the Stephenson Cancer Center in 2014. His interest in thoracic oncology started during his fellowship years at Tufts Medical Center in Boston, where he learned a broad spectrum of methods and approaches to treating thoracic malignancies. Aljumaily continues to build upon this knowledge through utmost patient care and extensive research, particularly, a phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant chemotherapy.

While in East Carolina University, he did a retrospective review of his experience treating lung cancer patients with oligometastatic disease. Dr. Aljumaily’s background inspires him to link basic science findings to clinical research ideas for patients with lung cancer.

Broadcast Time Zone is Eastern Standard Time (EST)
Approximately one week before the Conference, all registered delegates will receive an invitation with personal link to set their profile and enter the virtual Conference platform.  Your personal link will only be valid until the end of the Conference.  In order to view the Conference lectures and panel discussions, delegates must enter the virtual Conference platform and set their profile before the end of the Conference.